Juliana Casanovas de Carvalho

Juliana Casanovas de Carvalho

Auto-generated profile, based on publicly available information

Juliana Casanovas de Carvalho

Universidade Estadual do Maranhão

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
JCJuliana Casanovas de Carvalho
Juliana Casanovas de Carvalho
CACésar Augusto Abreu-Pereira
César Augusto Abreu-Pereira
LALucas Cauê da Silva Assunção
Lucas Cauê da Silva Assunção
RCRosana Costa Casanovas
Rosana Costa Casanovas
ASAna Abreu- Silva
Ana Abreu- Silva
.F. Matheus Levi Tajra Feitosa
. Matheus Levi Tajra Feitosa
Several axonal growth inhibitors have already been identified following spinal cord injury, the most known being myelin-derived proteins, such as Nogo-A. The present study aimed to correlate the formation of glial scar with the beginning of growth inhibitor, Nogo-A, release in rats previously submitted to compressive spinal cord injury. For this, 12 male and female Wistar rats (250 ± 50g) were divided into 3 groups of 4 animals each, according to the animals' euthanasia time after spinal cord injury (G3 - three days; G5 - five days; G7 - seven days). Spinal cord injuries were induced by means of dorsal laminectomy of the T10 vertebra and epidural compression. Histopathological evaluation and immunoreactivity of the Nogo-A axonal growth inhibitor were performed. It was observed that there was the release of the axonal inhibitor Nogo-A after 24h after the occurrence of spinal cord injury, and that the glial scar must be maintained, in this time interval, in order to guarantee the rebalancing of the post-trauma environment. Thus, it is suggested that the glial scar should be maintained in the acute phase of the lesion, guaranteeing its numerous benefits for the rebalancing of the post-injured environment and, after 24 hours, when the release of the studied axonal growth inhibitor begins, it should be removed.